According to IMARC Group latest report titled” Legionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on Legionella Testing market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global legionella testing market reached a value of US$ 261 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 424 Million by 2027, exhibiting at a CAGR of 8.38% during 2022-2027. Legionella is an infection that affects the lower respiratory tract, causing severe pneumonia, Pontiac fever, illnesses with flu-like symptoms, etc. Its testing helps in detecting the existence of bacteria or antigens in blood, urine, or sputum. Presently, numerous testing methods available for diagnosis of Legionella disease include urinary antigen, paired serology, Direct Fluorescent Antibody (DFA) stain, Polymerase Chain Reaction (PCR), the culture of lower respiratory secretions, etc. Based on the test results, antibiotic treatments like macrolides, tetracycline, quinolones, doxycycline, etc., are generally administered to patients.
Get a sample copy of this Report: https://www.imarcgroup.com/legionella-testing-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Trends:
The rising prevalence of numerous respiratory diseases, particularly among the geriatric population, is currently driving the global market for legionella testing. Additionally, several health agencies across multiple countries are developing an effective water safety plan (WSP) to reduce the spread of Legionella due to cooling towers, respiratory therapy equipment, water systems in hotels, homes, and factories, etc. Furthermore, the high mortality rate of legionella is augmenting the demand for its effective diagnostic tests and treatments, which will continue to propel the legionella testing market over the forecast period.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/legionella-testing-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Abbott Laboratories
- Becton
- Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc
- Eiken Chemical Co. Ltd
- Quidel Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc
Legionella Testing Market Segmentation:
Our report has categorized the market based on region, application and end use industry.
Breakup by Application:
- Water Testing
- Microbial Culture
- DFA Stain
- PCR
- Others
- IVD Testing
- Blood Culture
- Urine Antigen Test
- DFA Stain
- PCR
- Others
Breakup by End User:
- Hospitals and Clinics
- Diagnostic Laboratory
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800